Advantages and challenges of Tween 80 surfactant-enhanced technologies for the remediation of soils contaminated with hydrophobic organic compounds
Together, you'll review the results and explore various options, including Semaglutide and Tirzepatide
What does a degraded IGF-1 LR3 vial look like and how do you avoid it
Given that GLP-1 medications may prolong stomach residence time, documented protection through the point of consumption is a more defensible standard than no viability data at all
2025 GLP-1 Impacts Tell Us About CDMOs In 2026 By Louis Garguilo, Chief Editor, Outsourced Pharma When we began covering the nexus between GLP-1 drugs and CDMO capacity, there were two key questions: Could Novo Nordisk and Eli Lilly (and followers) keep up supply via internal and external manufacturing to meet exponential demand
orforglipron: Lillys small-molecule oral GLP-1 offering market-leading convenience and strategically advantageous pricing flexibility